Form 8-K - Current report:
SEC Accession No. 0001193125-23-137079
Filing Date
2023-05-05
Accepted
2023-05-05 16:05:57
Documents
12
Period of Report
2023-05-03
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d415922d8k.htm   iXBRL 8-K 34746
  Complete submission text file 0001193125-23-137079.txt   153054

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mrna-20230503.xsd EX-101.SCH 2855
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrna-20230503_lab.xml EX-101.LAB 17234
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrna-20230503_pre.xml EX-101.PRE 10815
6 EXTRACTED XBRL INSTANCE DOCUMENT d415922d8k_htm.xml XML 3222
Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 6177146500
Moderna, Inc. (Filer) CIK: 0001682852 (see all company filings)

EIN.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38753 | Film No.: 23893772
SIC: 2836 Biological Products, (No Diagnostic Substances)